Tiziano Martini

CO-39 | MYELOID CELL FUNCTION AND CYTOKINE PROFILES IN PEDIATRIC HEMOPHILIA A: INSIGHTS FROM FACTOR VIII AND EMICIZUMAB PROPHYLAXIS

Background and Aims. Haemophilia A (HA) is an X-linked bleeding disorder caused by factor VIII (FVIII) deficiency, treated with FVIII infusions or, more recently, emicizumab subcutaneously. Although emicizumab is safe and effective, FVIII is still required for severe bleeding, trauma, or surgery, and few studies have c...